Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5640
-0.0260 (-4.41%)
May 13, 2026, 4:00 PM EDT - Market closed
MTNB Market Cap
MTNB has a market cap or net worth of $3.61 million as of May 13, 2026. Its market cap has increased by 12.91% in one year.
Market Cap
3.61M
Enterprise Value
2.40M
1-Year Change
12.91%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $3.61M, a decrease of -98.38%. That is a compound annual growth rate of -36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 3.80M | - |
| Dec 31, 2025 | 3.80M | 46.15% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
| Mar 2, 2017 | 223.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.91M |
| Pulmatrix | 4.64M |
| GeoVax Labs | 4.28M |
| Alzamend Neuro | 3.99M |
| VivoSim Labs | 3.99M |
| Indaptus Therapeutics | 3.95M |
| 60 Degrees Pharmaceuticals | 3.88M |
| Galmed Pharmaceuticals | 3.82M |